Neurology News

The FDA has granted 510(k) clearance for marketing of an ablation system that creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures, according to the manufacturer.

Modifiable risk reduction strategies improved cognitive scores as well as dementia risk factors and quality of life for older adults at risk for dementia, according to study results published in JAMA Internal Medicine.

ORLANDO — Adjunctive treatment with brivaracetam led to significant seizure reduction and seizure freedom in a cohort of adults with focal onset epilepsy, according to interim results of a study.

The FDA has conferred with BrainStorm Cell Therapeutics Inc. regarding NurOwn, an investigational technology platform developed to treat amyotrophic lateral sclerosis.

As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.

ORLANDO — Earlier dose reductions of several concomitant antiseizure medications helped patients with uncontrolled focal seizures who require cenobamate administration, according to a poster at the American Epilepsy Society annual meeting.

ORLANDO — Among individuals with epilepsy, the prevalence of a major depressive disorder diagnosis was almost doubled compared with generalized anxiety disorder and varied by type of antiseizure medication used, according to a poster.

SAN DIEGO — Guideline-directed use of hydroxyurea may reduce cerebrovascular disease among individuals with sickle cell disease, according to single-center study results.

ORLANDO — A single provider intervention led to a high rate of portal activation that led to greater telemedicine use among Spanish-speaking families with pediatric neurology needs, according to a poster.

ORLANDO — Individuals with treatment-resistant focal epilepsy that required multiple antiseizure medications saw their seizure frequency significantly reduced after 1 year, according to a poster.